Pharnext (FR:ALPHA) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Pharnext SCA, a biopharmaceutical company focused on neurodegenerative diseases, has announced a capital reduction due to losses by decreasing the nominal value of its shares. The reduction is from 0.01 euro to 0.0002 euro per share, with a warn to investors about potential losses and dilution from rapid market sales and dilutive financing operations. Pharnext urges investors to exercise caution when investing in their securities.
For further insights into FR:ALPHA stock, check out TipRanks’ Stock Analysis page.
